Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Jun 28, 2022
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- Request for Proposals (RFP) Notice: Blueprint MedTech (BPMT) Biocompatibility, Sterilization, and Animal Studies
(NOT-DA-22-062)
National Institute on Drug Abuse
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
- Update: iEdison to Transition from NIH eRA to NIST; Downtime and Action Items Required in Preparation for August 9 Launch of New iEdison
(NOT-OD-22-158)
National Institutes of Health
- Request for Proposals (RFP) Notice: Research and Development for Clinical Studies in the Blueprint MedTech (BPMT)
(NOT-DA-22-063)
National Institute on Drug Abuse
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
Notice of Changes to Funding Opportunities
- Notice to Extend Expiration Date for PAR-20-276: Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
(NOT-CA-22-092)
National Cancer Institute
National Institute of Dental and Craniofacial Research
- Notice of Change to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional) in Eligibility
(NOT-TR-22-032)
National Center for Advancing Translational Sciences
Notices of Intent to Publish
- Notice of Intent to Publish Funding Opportunity Announcements for Resource Centers for Minority Aging Research (RCMARs) and AD/ADRD RCMARs (P30 Clinical Trial Optional)
(NOT-AG-22-023)
National Institute on Aging
- Notice of Intent to Publish a Funding Opportunity Announcement for Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional)
(NOT-AG-22-024)
National Institute on Aging
Notices of Special Interest
- Notice of Special Interest: Temporal Bone Histological Tissue Scanning Equipment Supplement
(NOT-DC-22-009)
National Institute on Deafness and Other Communication Disorders
- Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs
(NOT-NS-23-001)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
- Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity
(NOT-OD-22-135)
Office of Naval Research
John E. Fogarty International Center
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Office of AIDS Research
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Office of Dietary Supplements
Office of Research on Women's Health
- Notice of Special Interest (NOSI): Climate Change and Health Administrative Supplements
(NOT-TW-22-003)
John E. Fogarty International Center
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Sciences Research
Funding Opportunities
- Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
(PAR-22-173)
National Cancer Institute
Application Receipt Date(s): May 07, 2025 - Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
(PAR-22-174)
National Cancer Institute
Application Receipt Date(s): May 07, 2025 - Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
(PAS-22-196)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): September 05, 2025 - Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
(PAS-22-197)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): September 05, 2025 - Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed)
(RFA-AG-23-033)
National Institute on Aging
Application Receipt Date(s): October 21, 2022 - Therapeutic Development of Psychoplastogenic Compounds for Substance Use Disorders (R43/R44 - Clinical Trials Not Allowed)
(RFA-DA-23-017)
National Institute on Drug Abuse
Application Receipt Date(s): November 18, 2022
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail) or 335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail).
